Transcripts Neurocrine Biosciences, Inc.

Actions

NBIX

US64125C1099

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/07/2026			Varia. 5j.	Varia. 1 janv.
174,26 ^USD	+3,87 %		+3,41 %	+22,87 %

01/07	Neurocrine lance un essai de phase 2 pour le Crinecerfont chez les enfants de moins de 4 ans atteints d'hyperplasie congénitale des surrénales	MT
01/07	Neurocrine Biosciences lance une étude de phase 2 sur le crinecerfont chez les patients pédiatriques de moins de 4 ans atteints d'hyperplasie congénitale des surrénales classique	CI

Transcripts

09/06	Transcript : Neurocrine Biosciences, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 09:20 AM
02/06	Transcript : Neurocrine Biosciences, Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 10:40 AM
12/05	Transcript : Neurocrine Biosciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 11:20 AM
05/05	Transcript : Neurocrine Biosciences, Inc., Q1 2026 Earnings Call, May 05, 2026
17/03	Transcript : Neurocrine Biosciences, Inc. Presents at Stifel 2026 Virtual CNS Forum, Mar-17-2026 04:30 PM
09/03	Transcript : Neurocrine Biosciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08:40 AM
03/03	Transcript : Neurocrine Biosciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM
11/02	Transcript : Neurocrine Biosciences, Inc., Q4 2025 Earnings Call, Feb 11, 2026
12/01	Transcript : Neurocrine Biosciences, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:45 AM
17/12	Transcript : Neurocrine Biosciences, Inc. - Special Call
02/12	Transcript : Neurocrine Biosciences, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 09:30 AM
18/11	Transcript : Neurocrine Biosciences, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12:00 PM
28/10/25	Transcript : Neurocrine Biosciences, Inc., Q3 2025 Earnings Call, Oct 28, 2025
17/09/25	Transcript : Neurocrine Biosciences, Inc. Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit, Sep-17-2025 12:40 PM
09/09/25	Transcript : Neurocrine Biosciences, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 10:45 AM
03/09/25	Transcript : Neurocrine Biosciences, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-03-2025 01:00 PM
13/08/25	Transcript : Neurocrine Biosciences, Inc. Presents at Canaccord Genuity?s 45th Annual Growth Conference, Aug-13-2025 08:00 AM
31/07/25	Transcript : Neurocrine Biosciences, Inc., Q2 2025 Earnings Call, Jul 30, 2025
20/05/25	Transcript : Neurocrine Biosciences, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 11:30 AM
13/05/25	Transcript : Neurocrine Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11:20 AM
05/05/25	Transcript : Neurocrine Biosciences, Inc., Q1 2025 Earnings Call, May 05, 2025
18/03/25	Transcript : Neurocrine Biosciences, Inc. Presents at Stifel 2025 Virtual CNS Forum, Mar-18-2025 01:30 PM
11/03/25	Transcript : Neurocrine Biosciences, Inc. Presents at Leerink?s Global Healthcare Conference 2025, Mar-11-2025 11:20 AM
04/03/25	Transcript : Neurocrine Biosciences, Inc. Presents at TD Cowen 45th Annual Healthcare Conference, Mar-04-2025 11:10 AM
06/02/25	Transcript : Neurocrine Biosciences, Inc., Q4 2024 Earnings Call, Feb 06, 2025